Form D · Other Health Care
Biolyst, LLC
Minneapolis, MN · CIK 0001509117
Offering snapshot reported Aug 8, 2013 · SEC filing
- Reported sold
- $861K Offering amount: $1M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Jan 1, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 8, 2013 | Initial | $861,250 | No comparison | 20 | SEC filing |
| Aug 8, 2013 | Initial | $458,000 | No comparison | 15 | SEC filing |
| Dec 30, 2010 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $100K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-200983
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| BROKERBANK SECURITIES, INC. | 130116 |
Source: Form D, filed Aug 8, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alan Bignall | Director |
| Timothy Kelm | Director, Executive |
| Brian Stanton | Director |
| Philip Walter | Director, Executive, Promoter |
| Robert Weigel | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
601 Carlson Parkway Suite 1050
Minneapolis, MN, 55305
Minneapolis, MN, 55305